As livestock production faces increasing challenges, it can be difficult for producers to find the balance between meeting these challenges and maintaining profitability. Together dsm-firmenich and Novozymes have created Balancius® the first and only feed ingredient designed to unlock the hidden potential in gastrointestinal functionality.
Our experts are always available to help.
If you are an existing customer, please go directly to our Customer Portal.
Through its unique mode of action, this patented technology helps optimize nutritional absorption and digestion, so animals get more from their feed. An important contributor to immunity and gut health, Balancius® has also been shown to consistently improve feed conversion ratios (the amount of food produced in relation the amount of feed consumed) by 3%. That's a lot of rewards for a small addition.
By targeting the nutrition concealed in cell debris, Balancius® enables broilers to obtain more nutrition from the same amount of feed, enhancing poultry performance and chicken immune system. It thus improves their profitability, reduces their associated environmental footprint, and makes poultry farming more sustainable at one and the same time.
Developed by the dsm-firmenich and Novozymes Feed Enzymes Alliance, this breakthrough feed technology hydrolyzes peptidoglycans from bacterial cell debris in the intestinal tract.
In trials, it has been shown to improve the ability of broilers to absorb and digest nutrients like fats and proteins – as well as boosting the feed conversion ratio (the amount of food produced based on the amount of feed consumed) by up to 3%.
By increasing gut efficiency in poultry, Balancius® has the potential to reduce CO2 emissions by an estimated 9 million tons annually, on the basis of estimates produced by the UN Food and Agriculture Organization – the equivalent of taking 3.7 million cars off the road.
Through its unique mode of action, which involves targeting bacterial cell debris, this novel microbial muramidase helps optimize nutrient digestibility and absorption, ensuring that broilers get more from their feed to increase poultry performance, poultry gut health and poultry immunity.
Balancius® is designed to address the issues facing our industry. It demonstrates our commitment to bringing breakthrough, novel technology at scale to our customers, allowing them to continue to deliver healthy nutrition to a growing global population at affordable prices.
By targeting the nutrition concealed in cell debris, Balancius® enables swine to obtain more nutrition from the same amount of feed, enhancing swine performance and immune system. It thus improves their profitability, reduces their associated environmental footprint, and makes livestock farming more sustainable at one and the same time.
Developed by the DSM and Novozymes Feed Enzymes Alliance, this breakthrough feed technology hydrolyzes peptidoglycans from bacterial cell debris in the intestinal tract.
In trials, it has been shown to improve the ability of swine to absorb and digest nutrients like fats and proteins – as well as boosting the feed conversion ratio (the amount of food produced based on the amount of feed consumed).
By increasing gut efficiency in swine, Balancius® has the potential to reduce CO2 emissions by an estimated 9 million tons annually, on the basis of estimates produced by the UN Food and Agriculture Organization – the equivalent of taking 3.7 million cars off the road.
Through its unique mode of action, which involves targeting bacterial cell debris, this novel microbial muramidase helps optimize nutrient digestibility and absorption, ensuring that swine get more from their feed to increase swine performance, swine gut health and swine immunity.
Balancius® is designed to address the issues facing our industry. It demonstrates our commitment to bringing breakthrough, novel technology at scale to our customers, allowing them to continue to deliver healthy nutrition to a growing global population at affordable prices.
Certain statements may not be applicable in all geographical regions. Product associated claims may differ based on government requirements.
Product availability may vary by country, please contact us for more information.
Get in touch with a dsm-firmenich ANH specialist or find contacts around the world to suit your needs.
At dsm-firmenich, we love to connect with you.
Follow us on any of the channels below.
